{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:59:52Z","timestamp":1783735192563,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007699","name":"University of Georgia","doi-asserted-by":"publisher","award":["R01AI169892"],"award-info":[{"award-number":["R01AI169892"]}],"id":[{"id":"10.13039\/100007699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007699","name":"University of Georgia","doi-asserted-by":"publisher","award":["R01AI152533"],"award-info":[{"award-number":["R01AI152533"]}],"id":[{"id":"10.13039\/100007699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI172066"],"award-info":[{"award-number":["AI172066"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 AI050234"],"award-info":[{"award-number":["R37 AI050234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI109023"],"award-info":[{"award-number":["R01 AI109023"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI185559"],"award-info":[{"award-number":["R01 AI185559"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-039628"],"award-info":[{"award-number":["INV-039628"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-045096"],"award-info":[{"award-number":["INV-045096"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-033538"],"award-info":[{"award-number":["INV-033538"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["1 S10OD028697-01"],"award-info":[{"award-number":["1 S10OD028697-01"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.chembiol.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:45:48Z","timestamp":1751885148000},"page":"926-941.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity"],"prefix":"10.1016","volume":"32","author":[{"given":"Flore","family":"Nardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lushun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica J.","family":"Bohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhoja","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Okombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeson","family":"Calla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Macedo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Pazicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evie","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonlawat","family":"Boonyalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairi J.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Mayville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Laureano","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayland","family":"Treat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Tumwebaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Tjia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Montejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbynek","family":"Bozdech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus C.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratna","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay A.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4554-3119","authenticated-orcid":false,"given":"Debopam","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2025.06.003_bib1","unstructured":"WHO (2024). World malaria report 2024."},{"key":"10.1016\/j.chembiol.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"Rosenthal","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Liu","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib5","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/acs.jmedchem.3c02046","article-title":"Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164895","article-title":"Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia","volume":"11","author":"Kesely","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2025.06.003_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115043","article-title":"Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore","volume":"249","author":"Ong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib8","unstructured":"Gray, N.S., Zhang, T., Liu, Y., Weinstock, D., Li, L.S.-M. (2022) Benzimidazole derivatives and aza-benzimidazole derivatives as Janus Kinase 2 inhibitors and uses thereof. United States patent application 17\/291904, April 28, 2022."},{"key":"10.1016\/j.chembiol.2025.06.003_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2015.06.005","article-title":"Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia","volume":"28","author":"Wu","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molbiopara.2005.09.007","article-title":"High efficiency transfection of Plasmodium berghei facilitates novel selection procedures","volume":"145","author":"Janse","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41467-020-15440-4","article-title":"Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway","volume":"11","author":"LaMonte","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.06.003_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030949","article-title":"P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action","volume":"7","author":"Sanz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00034983.1975.11686997","article-title":"The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity","volume":"69","author":"Peters","year":"1975","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib15","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/ja104491h","article-title":"A coiled-coil enabled split-luciferase three-hybrid system: applied toward profiling inhibitors of protein kinases","volume":"132","author":"Jester","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2025.06.003_bib16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s41596-020-0310-z","article-title":"Cellular thermal shift assay for the identification of drug-target interactions in the Plasmodium falciparum proteome","volume":"15","author":"Dziekan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/cb500129t","article-title":"Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?","volume":"9","author":"Zhao","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00404-22","article-title":"Kinetic Tracking of Plasmodium falciparum Antigens on Infected Erythrocytes with a Novel Reporter of Protein Insertion and Surface Exposure","volume":"13","author":"Shao","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.chembiol.2025.06.003_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012627","article-title":"A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants","volume":"20","author":"Ferreira","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2025.06.003_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306420120","article-title":"The role of Plasmodium V-ATPase in vacuolar physiology and antimalarial drug uptake","volume":"120","author":"Alder","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2025.06.003_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk9893","article-title":"Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance","volume":"386","author":"Luth","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.06.003_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010926","article-title":"Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages","volume":"18","author":"Okombo","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/AAC.32.6.793","article-title":"Antimalarial agents: mechanisms of action","volume":"32","author":"Schlesinger","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2025.06.003_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00937-22","article-title":"Barcoding Genetically Distinct Plasmodium falciparum Strains for Comparative Assessment of Fitness and Antimalarial Drug Resistance","volume":"13","author":"Carrasquilla","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.chembiol.2025.06.003_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/acsinfecdis.0c00724","article-title":"Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities","volume":"7","author":"Arendse","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj3470255","article-title":"PfPK6, a novel cyclin-dependent kinase\/mitogen-activated protein kinase-related protein kinase from Plasmodium falciparum","volume":"347","author":"Bracchi-Ricard","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2025.06.003_bib32","doi-asserted-by":"crossref","first-page":"13172","DOI":"10.1021\/acs.jmedchem.2c00996","article-title":"Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial PfGSK3\/PfPK6 with Activity against Blood Stage Parasites In Vitro","volume":"65","author":"Galal","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0166-6851(93)90252-S","article-title":"Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand","volume":"57","author":"Wilson","year":"1993","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2025.06.003_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2025.06.003_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/infdis\/jix334","article-title":"Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity","volume":"216","author":"Agrawal","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"18883","DOI":"10.1073\/pnas.0911317106","article-title":"Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine","volume":"106","author":"Sa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1038\/ncomms7715","article-title":"Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate","volume":"6","author":"Hameed P","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bcp.2009.12.025","article-title":"Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death","volume":"79","author":"van Schalkwyk","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib40","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/sj.emboj.7600681","article-title":"A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance","volume":"24","author":"Lakshmanan","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2025.06.003_bib41","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.1021\/acs.jmedchem.0c01411","article-title":"Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse Model","volume":"63","author":"Horatscheck","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejmech.2018.09.060","article-title":"Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites","volume":"159","author":"L'Abbate","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib43","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/acs.jmedchem.6b01641","article-title":"Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model","volume":"60","author":"Singh","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib44","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1021\/acs.jmedchem.4c01154","article-title":"2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy","volume":"67","author":"Dziwornu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acschembio.5b01063","article-title":"Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors","volume":"11","author":"Klaeger","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071571","article-title":"Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites","volume":"25","author":"de Sousa","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2025.06.003_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-6851(00)00261-9","article-title":"Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine","volume":"110","author":"Dzekunov","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/infdis\/jiac365","article-title":"Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials","volume":"226","author":"Wicht","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011436","article-title":"PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport","volume":"19","author":"Gomez","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2025.06.003_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.pt.2023.06.001","article-title":"Developing kinase inhibitors for malaria: an opportunity or liability?","volume":"39","author":"Mogwera","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics","volume":"359","author":"Cowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib69","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1473-3099(19)30543-2","article-title":"Plasmodium falciparum resistance to piperaquine driven by PfCRT","volume":"19","author":"Dhingra","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ijpara.2024.04.011","article-title":"Optimized plasmid loading of human erythrocytes for Plasmodium falciparum DNA transfections","volume":"54","author":"Mohammad","year":"2024","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chembiol.2021.06.006","article-title":"The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance","volume":"29","author":"Murithi","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib57","unstructured":"Gray, N.S., Zhang, T., Lui, Y., Weinstock, D., Li, L.S.-M. (2021) Tricyclic kinase inhibitors and uses thereof."},{"key":"10.1016\/j.chembiol.2025.06.003_bib58","unstructured":"Gray, N.S., Zhang, T., Lui, Y., Weinstock, D., Li, L.S.-M. (2020) Benzimidazole derivatives and aza-benzimidazole derivatives as Janus Kinase 2 inhibitors and uses thereof."},{"key":"10.1016\/j.chembiol.2025.06.003_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12936-015-1011-x","article-title":"An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs","volume":"14","author":"Dery","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.chembiol.2025.06.003_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9446","article-title":"Open-source discovery of chemical leads for next-generation chemoprotective antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2025.06.003_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.chembiol.2023.10.025","article-title":"Antiplasmodial peptaibols act through membrane directed mechanisms","volume":"31","author":"Collins","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib61","unstructured":"Pazicky, S., Bozdech, Z. (2025). 10.5281\/zenodo.15636573."},{"key":"10.1016\/j.chembiol.2025.06.003_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50385-9","article-title":"Protein quantification and visualization via ultraviolet-dependent labeling with 2,2,2-trichloroethanol","volume":"9","author":"Chopra","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2025.06.003_bib54","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2025.06.003_bib64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib65","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1073\/pnas.1018449108","article-title":"Asparagine repeat function in a Plasmodium falciparum protein assessed via a regulatable fluorescent affinity tag","volume":"108","author":"Muralidharan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2025.06.003_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073783","article-title":"Inducible knockdown of Plasmodium gene expression using the glmS ribozyme","volume":"8","author":"Prommana","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2025.06.003_bib67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijpara.2018.03.009","article-title":"Guide RNA selection for CRISPR-Cas9 transfections in Plasmodium falciparum","volume":"48","author":"Ribeiro","year":"2018","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12936-021-03816-w","article-title":"Improved Plasmodium falciparum dilution cloning through efficient quantification of parasite numbers and c-SNARF detection","volume":"20","author":"Macedo-Silva","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.chembiol.2025.06.003_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01832-23","article-title":"Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology","volume":"15","author":"Hagenah","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.chembiol.2025.06.003_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12936-015-0729-9","article-title":"Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials","volume":"14","author":"Combrinck","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.chembiol.2025.06.003_bib72","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2025.06.003_bib73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2025.06.003_bib74","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib75","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chembiol.2025.06.003_bib76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.chembiol.2025.06.003_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.chembiol.2025.06.003_bib78","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S2666-5247(21)00085-9","article-title":"Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study","volume":"2","author":"Tumwebaze","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.chembiol.2025.06.003_bib79","article-title":"Selection of artemisinin partial resistance Kelch13 mutations in Uganda in 2016-22 was at a rate comparable to that seen previously in South-East Asia","author":"Meier-Scherling","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.chembiol.2025.06.003_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11901","article-title":"A broad analysis of resistance development in the malaria parasite","volume":"7","author":"Corey","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2025.06.003_bib81","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization of Molecular Targets for Antimalarial Drug Discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2025.06.003_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14240","article-title":"Esterase mutation is a mechanism of resistance to antimalarial compounds","volume":"8","author":"Istvan","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625001989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945625001989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:52:48Z","timestamp":1778889168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945625001989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2451945625001989"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.06.003","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}